Trending

M&B Engineering IPO sees slow Day 1; GMP edges over 11 %

Institutionals yet to bite - retail books filling; grey market signals modest listing premium

Institutionals yet to bite - retail books filling; grey market signals modest listing premiumAI-generated image

M&B Engineering's IPO may be drawing buzz in the grey market, but the actual subscription is surprisingly underwhelming. While investors are expecting listing gains, only a small fraction of the issue has been bid for so far, raising questions over demand. Let’s unpack what’s really going on and what it means for patient investors.

Why is the subscription slow?

Grey market premium is already healthy at Rs 43, an implied listing gain of slightly over 11 per cent over the Rs 385 upper band. But with institutional interest lukewarm, enthusiasm may be driven more by speculation than fundamentals.

Day 1 subscription status

  • Total: 0.20x
  • QIBs: 0
  • NIIs: 0.17x
  • Retail: 0.82x

What it means for investors

A slim first‑day subscription suggests caution among institutional investors; most of the demand so far comes from retail. That contrast, between a strong GMP and weak underwriting interest, may point to short‑term trading appetite rather than conviction in fundamentals.

At a projected Rs 2,200 crore post‑issue market cap, M&B slots into small‑cap industrial terrain. While its integrated operations and export traction impress, risks remain: raw‑material cost swings, narrow sector focus, and pressure if demand doesn’t scale fast. Brokers recommend “subscribe for the long term” but warn that the issue appears fully valued.

About the company

Established in 1981, M&B Engineering offers comprehensive solutions in pre-engineered buildings (PEBs) and self-supported steel roofing, with two manufacturing plants located in Gujarat and Tamil Nadu. Total capacity exceeds 1.03 lakh MTPA PEB and 1.8 million square meters per annum steel roofing. It has completed over 9,500 projects across 22 countries for clients like Adani Group, Tata Advanced Systems and Alembic Pharma.

Should you apply to the M&B Engineering IPO?

If you're considering this IPO, temper the GMP hype with sober realism. Early grey market gains can seem alluring, but meaningful wealth building often comes from picking established stocks with consistent performance, not merely chasing the initial pop – especially with institutions still on the sidelines.

Value Research Stock Advisor focuses on exactly that – expert-picked stocks, time-tested strategies and portfolios built for long-term wealth. Stop chasing IPO noise. Start building lasting value.

Explore Stock Advisor today

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Other Categories